ELV
Elevance Health Inc
395.90$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.2% | -22.1% | +30.6% | -8.5% | +58.4% | +76.3% | -21.7% | +0.4% | -4.0% | -27.9% | -26.1% | |
| – | +6.7% | +0.4% | -2.3% | +26.6% | +0.5% | +1.9% | +12.8% | +28.6% | +4.2% | -20.2% | +11.0% | |
| – | -12.3% | +11.1% | +3.0% | +33.3% | +30.1% | -3.7% | -9.9% | +3.5% | +9.5% | -33.9% | +44.5% | |
| – | -183.6% | – | -310.5% | – | +3.6% | -124.0% | – | -150.0% | – | – | – | |
| – | – | -179.1% | – | -535.4% | – | – | -84.9% | -67.7% | -311.5% | – | – | |
| – | -3.8% | -3.2% | +35.4% | +52.9% | -10.8% | -5.2% | +6.5% | +6.0% | +12.5% | -3.1% | -11.1% | |
| – | +18.1% | -55.4% | +889.0% | -75.2% | +121.8% | +162.3% | +31.6% | -52.7% | +22.2% | -7.3% | -74.0% | |
| – | +36.6% | +4.2% | +3.1% | +10.1% | +5.4% | +16.6% | +15.7% | +11.3% | +13.5% | +8.1% | +1.4% | |
| – | -49.5% | -95.6% | +2,881.6% | -15.7% | +0.9% | +58.7% | -29.6% | +21.9% | +15.5% | +8.4% | -10.2% | |
| – | -216.9% | – | +932.8% | -134.8% | – | -168.0% | – | -51.2% | -58.8% | +652.6% | -58.2% | |
| – | +64.5% | -75.5% | – | -624.9% | +1.1% | +13.3% | – | -411.6% | +154.1% | – | -245.7% | |
| – | -106.8% | – | -123.8% | – | +208.6% | -19.8% | -207.1% | – | -134.3% | – | -31.7% | |
| – | +28.1% | -25.4% | +29.5% | -22.8% | +90.3% | +94.0% | -24.7% | -0.4% | -6.7% | -32.7% | -30.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.